Zurueck zur Suche

Reporte zur Charge UT7695LA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

16Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 5 TX 3 OH 2 VA 2 LA 1 MA 1 SC 1 AR 1

VAERS 2511671

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

mild
Staat
TX
Alter
0,6
Geschlecht
F
Eingang
18.11.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema

Symptomtext

Parent noticed a red spot near injection site the night the vaccine was given. Was also given Prevnar vaccine same day and same leg, however has tolerated prevnar well in the past with no reaction.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2503143

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

mild
Staat
MI
Alter
9,0
Geschlecht
M
Eingang
09.11.2022
Impfdatum
07.11.2022
Beginn
08.11.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pyrexia Somnolence

Symptomtext

Patient's mom called our office on 11/8/22 stating the patient was falling asleep in gym class and had a 101 fever. Advised mom to give tylenol and motrin if needed for comfort and assured her that this is a common reaction that should only last a day or two.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
ADHD, Autism
Andere Medikamente
Concerta
Allergien
NKA
Vorherige Impfungen
-

VAERS 2495390

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

mild
Staat
LA
Alter
6,0
Geschlecht
M
Eingang
01.11.2022
Impfdatum
27.10.2022
Beginn
28.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abnormal behaviour Hypersomnia Hypophagia Injection site erythema Injection site reaction Injection site streaking Purulent discharge Respiratory tract congestion Scab Skin warm

Symptomtext

Mom states after patient got his flu vaccine it looked like he had a red line at injection site. Says it looked like needle went in sideways-mom says she was watching and it didn't. She says it then started to look like a line of pus and then it got bigger. Went to urgent care Sunday-was prescibed mupirocen and bactrim- started both last night. States it is now crusted over this morning. Pt has some slight congestion. No cough or NVD. Pt felt warm last night-unsure about fever. Pt has not been eating much and has not been acting like himself. Sleeping more.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
10/20/22: 1)VIRAL URI (ICD10-J06.9) - New - 2)Acute serous otitis media, bilateral (ICD10-H65.03) - New - 3)Acute cough (ICD10-R05.1) - New - 4)Leukocytes in urine (ICD10-R82.79) - New - 9/16/22: 1)VIRAL URI (ICD10-J06.9) - New - 2)Acute serous otitis media, bilateral (ICD10-H65.03) - New - 3)Acute cough (ICD10-R05.1) - New - 4)Leukocytes in urine (ICD10-R82.79) - New -
Vorgeschichte
-
Andere Medikamente
Loratadine 5mg/5mL 5mL PO q day Cyproheptadine 4mg tabs 2mg PO bid Multivitamin with fluoride 1 tab PO q day
Allergien
PCN
Vorherige Impfungen
-

VAERS 2490955

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

mild
Staat
MA
Alter
4,0
Geschlecht
M
Eingang
27.10.2022
Impfdatum
25.10.2022
Beginn
-
Tage bis Beginn
-
Dosis
6
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration Injection site pain No adverse event

Symptomtext

There has been no adverse reaction to date. This dose was given too soon. Instead of 8 weeks between the 2nd and 3rd dose there was only 4 weeks. Only symptom experienced was soreness at the site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Sodium Fluoride 0. 5 mg Daily
Allergien
None
Vorherige Impfungen
-

VAERS 2685098

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7695la

gering
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
22.09.2023
Impfdatum
05.12.2022
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

Nurse administered meningococcal B vaccine instead of meningococcal conjugate. No adverse reaction reported by parent or patient

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NO
Vorgeschichte
NO
Andere Medikamente
NO
Allergien
NO
Vorherige Impfungen
-

VAERS 2634513

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
OH
Alter
16,0
Geschlecht
F
Eingang
20.05.2023
Impfdatum
19.12.2022
Beginn
19.12.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy No adverse event Pregnancy test positive

Symptomtext

another pregnancy test was done and it was positive with no reported adverse event; Initial information received on 15-May-2023 regarding an unsolicited valid non-serious case received from a physician. This case involves a 16 years old female patient who was had to vaccine influenza quadrival a-b vaccine [fluzone qiv] in context of another pregnancy test was done and it was positive with no reported adverse event. Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported another pregnancy test was done and it was positive with no reported adverse event occurred at unknown gestation period. The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies. Concomitant medications included meningococcal vaccine a/c/y/w conj (tet tox) (menquadfi) for prophylactic vaccination; and meningococcal vaccine b (meningococcal vaccine b) for Immunisation. On 19-Dec-2022, the patient received 0.5 ml once of suspect influenza quadrival a-b vaccine Suspension for injection lot UT7695LA via unknown route, strength, expiration date in unknown administration site for immunisation. On 19-Dec-2022 the patient developed a non-serious another pregnancy test was done and it was positive with no reported adverse event (exposure during pregnancy)(latency: same day). Relevant prenatal testing after exposure included was unknown. Relevant laboratory test results included: Pregnancy test - On 19-Dec-2022: Negative; on an unknown date: Positive Action taken was not applicable. Outcome: Unknown for the event another pregnancy test was done and it was positive with no reported adverse event. Additionally, at time of reporting, the outcome of the pregnancy is unknown.; Sender's Comments: US-SA-2023SA151221:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
Test Date: 20221219; Test Name: pregnancy Test; Test Result: Negative ; Test Name: Pregnancy test; Test Result: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MENQUADFI; MENINGOCOCCAL VACCINE B
Allergien
-
Vorherige Impfungen
-

VAERS 2569356

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
MI
Alter
1,0
Geschlecht
F
Eingang
27.01.2023
Impfdatum
16.12.2022
Beginn
27.01.2023
Tage bis Beginn
42,0
Dosis
2
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

NO ADVERS EVENT HAPPENED

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2562298

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
MI
Alter
27,0
Geschlecht
M
Eingang
18.01.2023
Impfdatum
16.01.2023
Beginn
16.01.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

A pediatric dose of HepB was accidentally administered to client instead of an adult dose. Client was contacted and informed of the incident. Staff also explained that because it was a pediatric dose, it would be considered invalid and he would need to receive an adult dose of HepB to complete the series. Staff scheduled client an appointment on 1/18/23 and an adult dose of HepB was administered. Second, the HPV9 was pulled from the inventory and it should have been taken from the private vaccine inventory. Due to client's age, he does not qualify for program. This dose will be replaced with private pay and private vaccine loss report will be completed by my supervisor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None reported.
Vorgeschichte
None reported.
Andere Medikamente
None reported.
Allergien
None reported.
Vorherige Impfungen
-

VAERS 2556175

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
MI
Alter
7,0
Geschlecht
F
Eingang
10.01.2023
Impfdatum
10.01.2023
Beginn
10.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered No adverse event

Symptomtext

There was no adverse reaction at time of reporting. Pfizer Bivalent was given in error. Monovalent should have been administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
No
Aktuelle Erkrankungen
No
Vorgeschichte
NO
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2556149

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
MI
Alter
9,0
Geschlecht
M
Eingang
10.01.2023
Impfdatum
06.01.2023
Beginn
06.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product use issue

Symptomtext

There was no adverse reaction. Pfizer Bivalent was administered in error after beyond use date. Client will come back for a bivalent dose that is not beyond use date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2510400

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
TX
Alter
13,0
Geschlecht
M
Eingang
17.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

vaccine was administered subcutaneously instead of intramuscularly with no reported adverse event; Initial information received on 09-Nov-2022 regarding an unsolicited valid non-serious case from other health professional. This case involves a 13 years old male patient to whom INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV] was administered subcutaneously instead of intramuscularly with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A), HPV VACCINE, HEPATITIS B VACCINE (HEPATITIS B [HEPATITIS B VACCINE]) and MENINGOCOCCAL VACCINE for Immunisation. On 24-Oct-2022, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE at a dose of 0.5 ml once (lot UT7695LA, expiry date: 30-Jun-2023) via subcutaneous route in the left arm for prophylactic vaccination. On 24-Oct-2022 the patient developed a non-serious vaccine was administered subcutaneously instead of intramuscularly with no reported adverse event (incorrect route of product administration, latency: same day). It was reported that a patient was administered the vaccine with a 5/8 inch needle instead of the recommended needle and the vaccine was administered subcutaneously instead of intramuscularly. Wanting to know if the dose needs to be repeated. Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
HEPATITIS A; HPV VACCINE; HEPATITIS B [HEPATITIS B VACCINE]; MENINGOCOCCAL VACCINE
Allergien
-
Vorherige Impfungen
-

VAERS 2501794

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
SC
Alter
0,2
Geschlecht
F
Eingang
08.11.2022
Impfdatum
08.11.2022
Beginn
08.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

inadvertent administration of Flu vaccine. No adverse effects noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Infant mylicon gas drops as needed
Allergien
None
Vorherige Impfungen
-

VAERS 2497701

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT7695LA

gering
Staat
OH
Alter
12,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Patient was given COVID Bivalent instead of COVID monovalent. Patient had previously only received one COVID vaccine. Patient has not had any adverse reactions to vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Anxiety
Andere Medikamente
Fluoxetine
Allergien
N/A
Vorherige Impfungen
-

VAERS 2490996

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge UT7695LA

gering
Staat
VA
Alter
11,0
Geschlecht
F
Eingang
26.10.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered

Symptomtext

Nurse gave 5-1 BIV as primary series as current recommendation states 5-11 BIV for booster dose only. Patient observed for 15 min post exposure. Discharged WNL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2490993

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge UT7695LA

gering
Staat
VA
Alter
6,0
Geschlecht
M
Eingang
26.10.2022
Impfdatum
24.10.2022
Beginn
24.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Incorrect product formulation administered No adverse event

Symptomtext

Nurse gave 5-11 BIV as primary series as current recommendation state 5-11 BIV for booster dose only. Patient observed for 15 min post exposure. Discharged WNL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Cough
Vorgeschichte
none
Andere Medikamente
-
Allergien
None
Vorherige Impfungen
-

VAERS 2478519

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge ut7695la

gering
Staat
AR
Alter
0,3
Geschlecht
M
Eingang
14.10.2022
Impfdatum
13.10.2022
Beginn
13.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Infant irritability Product administered to patient of inappropriate age

Symptomtext

influenza vaccine given at 4 months of age along with routine vaccines. child did run fever of 100 and was very fussy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Infant irritability
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-